Blog
RSS FeedPosted by Michael Wonder on 12 Oct 2021
Outdated criteria for drug plan reimbursement obstruct evidence based care
12 October 2021 - An important flaw in the funding approach used by Canada’s public drug plans is highlighted by the ...
Posted by Michael Wonder on 25 Sep 2021
Ontario providing access to life changing treatment for cystic fibrosis patients
24 September 2021 - Ontario is now providing coverage for Trikafta, the latest and most effective treatment option for cystic fibrosis ...
Posted by Michael Wonder on 21 Aug 2021
Cystic fibrosis patients, advocates urge Ontario government to provide ‘miracle drug’ funding
20 August 2021 - An Ontario teen living with Cystic Fibrosis and her mother are hoping to shine a light ...
Posted by Michael Wonder on 25 May 2021
Dupixent (dupilumab) now publicly reimbursed in Ontario and New Brunswick for the treatment of moderate to severe atopic dermatitis
25 May 2021 - Dupixent is the only biologic medicine approved by Health Canada to treat moderate to severe atopic dermatitis. ...
Posted by Michael Wonder on 29 Apr 2021
Valeo Pharma’s Redesca and Redesca HP to be covered under the Ontario Public Drug Benefit Program
28 April 2021 - Additional provincial coverage expected to follow. ...
Posted by Michael Wonder on 19 Mar 2021
Cystic fibrosis patients call on Premier Ford to provide immediate access to life saving treatments
18 March 2021 - Ontarians with cystic fibrosis made an emotional plea to Premier Ford this week in a video that ...
Posted by Michael Wonder on 21 Feb 2021
Ontario makes commitment to funding CF drugs after approval process completed
19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...
Posted by Michael Wonder on 10 Dec 2020
Ontario to begin vaccinations next week in Toronto, Ottawa
10 December 2020 - The first vaccines will go to health care workers at long-term care homes and other high-risk ...
Posted by Michael Wonder on 12 Oct 2020
Radiopharmaceutical cancer treatment Lutathera now available to Ontario patients with midgut neuroendocrine tumours
8 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs. ...
Posted by Michael Wonder on 26 Jan 2020
Pickering, Ont. mother living with cystic fibrosis approved for miracle drug: ‘I’m in shock’
24 January 2020 - A Pickering, Ont. mother fighting cystic fibrosis has received her late Christmas wish. ...
Posted by Michael Wonder on 18 Nov 2019
Ontario and Quebec provide reimbursement for HIV therapies Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate)
18 November 2019 - For more than 30 years, Merck has been committed to scientific research and discovery in HIV that ...
Posted by Michael Wonder on 13 Sep 2019
Medexus reports Health Quality Ontario recommends Gliolan for public reimbursement
12 September 2019 - Medexus Pharmaceuticals today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology ...
Posted by Michael Wonder on 14 Jun 2019
Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy
13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...
Posted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 21 Mar 2019
Why Ontario parents could soon be paying more for prescription drugs
22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...